
We had a productive day in Houston at the 39th Annual Meeting of #SITC24 last week, engaging with industry experts and presenting #preclinical data on LY6G6D. We appreciate everyone who visited our poster to learn more about our efforts toward advancing CB21 for MSS CRC patients.

